Sort
17,288 grants matching “multiple sclerosis”
A Single-cell Platform for Analyzing the Peripheral Immune Response in Alzheimerâs and Alzheimerâs Related Diseases
$994,372Timothy S McConnell · Isoplexis, Inc. · R44 · FY2021 · AG
A polymeric biomaterial-based vaccine utilizing immunomodulatory agents and antigen for the amelioration of type 1 diabetes.
$993,629Benjamin Michael Looney · Inspira Therapeutics, Inc. · R44 · FY2021 · DK
PROTEOMIC DETERMINANTS AND COMPONENTS OF PROGRESSION IN MULTIPLE SCLEROSIS
$993,283Regents Of The University Of California, San Francisco, The · · FY2025 · Defense Health Agency
AUTOIMMUNITY CENTERS OF EXCELLENCE
$992,726Columbia University Health Sciences · U19 · FY2000 · AI
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$992,711Dorothy Anne Cross · Washington University · P01 · FY2012 · NS
MECHANISMS OF IGG ANTIBODY-MEDIATED NEURONAL CYTOTOXICITY IN MULTIPLE SCLEROSIS
$992,377The Regents Of The University Of Colorado · · FY2024 · Defense Health Agency
IN VIVO IMAGING OF FIBRIN DEPOSITION AND ITS CORRELATES IN MULTIPLE SCLEROSIS
$992,135The General Hospital Corporation · · FY2022 · Defense Health Agency
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$991,718Dorothy Anne Cross · Washington University · P01 · FY2008 · NS
Epidemiology of Aging and Dementia-Autopsy Research
$991,717Lon Ray White · Kuakini Medical Center · U01 · FY2010 · AG
IEDB for Multiple sclerosis, Rheumatoid Arthritis, Lupus, and Type 1 Diabetes
$990,248Alessandro Sette · La Jolla Institute For Immunology · N01 · FY2014 · AI
A Novel Tolerance Therapeutic for Treating Multiple Sclerosis
$990,104Neil A Fanger · Virtici, Llc · R44 · FY2018 · AI
Nuclear receptors: action, functions, and roles in disease
$989,992Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$989,984Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
Epidemiology of Aging and Dementia-Autopsy Research
$989,777Lon Ray White · Kuakini Medical Center · R01 · FY2006 · AG
A polymeric biomaterial-based vaccine utilizing immunomodulatory agents and antigen for the amelioration of type 1 diabetes.
$989,307Benjamin Michael Looney · Onevax, Llc · R44 · FY2020 · DK
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
$987,822Justin Kawika Ichida · University Of Southern California · R01 · FY2023 · NS
A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis
$987,225Gary Fanger · Rise Therapeutics, Llc · R44 · FY2024 · AG
Super resolution microscope for the imaging core facility
$987,190Hiroshi Nishimune · University Of Kansas Medical Center · S10 · FY2019 · OD
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
$986,054Justin Kawika Ichida · University Of Southern California · R01 · FY2024 · NS
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$985,870Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Epidemiology of Aging and Dementia - Autopsy Research
$985,387Lon Ray White · Kuakini Medical Center · U01 · FY2009 · AG
IMMUNOGENETICS OF DEMYELINATION
$985,119Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2001 · NS
Sensory motor transformations in human cortex
$985,068Richard A Andersen · California Institute Of Technology · U01 · FY2023 · NS
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$984,329Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Epidemiology of Aging and Dementia - Autopsy Research
$984,013Lon Ray White · Kuakini Medical Center · U01 · FY2008 · AG